Lakó Ágnes, Molnár Zsófia, Mendonça Ricardo, Poppe László
Department of Organic Chemistry and Technology, Budapest University of Technology and Economics Műegyetem rkp. 3 1111 Budapest Hungary
Hovione Farmaciência, S.A., Campus do Lumiar Edifício R, Estrada do Paço do Lumiar 1649-038 Lisboa Portugal.
RSC Adv. 2020 Nov 10;10(67):40894-40903. doi: 10.1039/d0ra08134e. eCollection 2020 Nov 9.
Transaminases (TAs) offer an environmentally and economically attractive method for the direct synthesis of pharmaceutically relevant disubstituted 1-phenylpropan-2-amine derivatives starting from prochiral ketones. In this work, we report the application of immobilised whole-cell biocatalysts with ()-transaminase activity for the synthesis of novel disubstituted 1-phenylpropan-2-amines. After optimisation of the asymmetric synthesis, the ()-enantiomers could be produced with 88-89% conversion and >99% ee, while the ()-enantiomers could be selectively obtained as the unreacted fraction of the corresponding racemic amines in kinetic resolution with >48% conversion and >95% ee.
转氨酶(TAs)为从手性前体酮直接合成具有药学相关性的二取代1-苯基丙-2-胺衍生物提供了一种环境友好且经济可行的方法。在本研究中,我们报道了具有()-转氨酶活性的固定化全细胞生物催化剂在新型二取代1-苯基丙-2-胺合成中的应用。经过不对称合成优化后,()-对映体的转化率可达88-89%,对映体过量值(ee)>99%,而在动力学拆分中,()-对映体可作为相应外消旋胺的未反应部分选择性获得,转化率>48%,ee>95%。